OKYO Pharma receives FDA feedback on phase 3 neuropathic pain trial

Investing_ng | 09-07-2026 12:07am |

OKYO Pharma receives FDA feedback on phase 3 neuropathic pain trial

Related Articles

How suspected cultists killed hotel mana... Top
Tinubu receives Patriots group, to consi... Top
Why I’m making movie about prison refo... Entertainment
400 terrorists, others at large two year... Top
Naval officer dies rescuing 59 from drow... Top
Quality education for young population i... Top

Stay Updated with the Latest News!

Don't miss out on breaking stories and in-depth articles.

See the latest News